<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HF6E151E45B6F4FB8BD3B371A1725A54C" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 4509 IH: NOPAIN for Veterans Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-07-17</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4509</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250717">July 17, 2025</action-date><action-desc><sponsor name-id="L000601">Mr. Landsman</sponsor> (for himself, <cosponsor name-id="V000135">Mr. Van Orden</cosponsor>, <cosponsor name-id="P000614">Mr. Pappas</cosponsor>, <cosponsor name-id="B001301">Mr. Bergman</cosponsor>, <cosponsor name-id="S001185">Ms. Sewell</cosponsor>, and <cosponsor name-id="H001098">Mr. Hamadeh of Arizona</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HVR00">Committee on Veterans' Affairs</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title 38, United States Code, to ensure that the Secretary of Veterans Affairs furnishes certain non-opioid pain medications to veterans, and for other purposes.</official-title></form><legis-body id="H947AED07CCC543C6B25804D43474A0D1" style="OLC"> 
<section id="H66E0A611AA0047D9A8D2F2B3A7374554" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>NOPAIN for Veterans Act</short-title></quote>.</text></section> <section id="HB879EFCD52BE42C0841432EED5066986"><enum>2.</enum><header>Inclusion of certain non-opioid pain medications in the National Formulary of the Department of Veterans Affairs</header> <subsection id="HDA939E1193AA4B54A15BF8DBFF7D3E3A"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 8125 of title 38, United States Code, is amended—</text>
<paragraph id="HD22F3CC665E34F31A63FDD8D5CAC9CEE"><enum>(1)</enum><text display-inline="yes-display-inline">in subsection (d), by adding at the end the following new paragraph:</text> <quoted-block style="USC" id="HA023B627251E4A22AB4A6F63ADDA676D" display-inline="no-display-inline"> <paragraph id="H2C78E619BF974091B293E082EC32039C"><enum>(4)</enum><text display-inline="yes-display-inline">The term <term>non-opioid pain management drug or biological product</term> means a drug or biological product approved, granted, or cleared by the Food and Drug Administration to reduce postoperative pain, or to produce postsurgical or regional analgesia, without acting upon the body’s opioid receptors.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph>
<paragraph id="HB562D974A7CE457EA8BB36DBF12B7ABC"><enum>(2)</enum><text>by redesignating subsection (d), as so amended, as subsection (e); and</text></paragraph> <paragraph id="HB3C05172AF89412099023B1A095731E5"><enum>(3)</enum><text>by inserting, after subsection (c), the following new subsection (d):</text>
<quoted-block style="USC" id="HF943A0728A174F14AA5BC1B352E87C1E" display-inline="no-display-inline">
<subsection id="HDE04C481445B40CE8A0E639C3B47B564"><enum>(d)</enum><text>The Secretary shall—</text> <paragraph id="H32C9DCCCB7D045C2AF2CF2BCA7A6E7CF"><enum>(1)</enum><text display-inline="yes-display-inline">not later than one year after the date on which a non-opioid pain management drug or biological product becomes eligible for temporary additional payment under section 1833(t)(16)(G) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395l">42 U.S.C. 1395l(t)(16)(G)</external-xref>), or eligible for separate payment under section 416.174 of title 42, Code of Federal Regulations (or successor regulation), include such non-opioid pain management drug or biological product in the national formulary of the Department; and</text></paragraph>
<paragraph id="HF2C280DDA36D456CA223F60A6D40A61E"><enum>(2)</enum><text display-inline="yes-display-inline">include a non-opioid pain management drug or biological product in the drug standardization list of the Department.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection> <subsection id="HED3907978DDE4F6BA95F38BAF3470771" commented="no"><enum>(b)</enum><header>Limitation</header><text display-inline="yes-display-inline">None of the funds in the Cost of War Toxic Exposures Fund under section 324 of title 38, United States Code, may be used to carry out the amendments made by this section.</text></subsection>
<subsection id="HB077CCF917D748B596B41A9A9CEE766C"><enum>(c)</enum><header>Implementation</header><text display-inline="yes-display-inline">Not later than 90 days after the date of the enactment of this Act, the Secretary of Veterans Affairs shall implement the amendments made by this section.</text></subsection></section> </legis-body></bill>

